Literature DB >> 2936535

Radioimmunoassay of atrial natriuretic peptides in human plasma.

E Hartter, W Woloszczuk, H K Stummvoll.   

Abstract

The concentration of atrial natriuretic peptide (hANP) in plasma from venous blood of healthy subjects was measured by radioimmunoassay. hANP from 5 mL of EDTA-treated plasma was adsorbed onto Sep-Pak C18 cartridges, which were eluted with methanol/trifluoroacetic acid (5 mL/L), 90/10 by volume. The eluates were concentrated by evaporation under nitrogen and lyophilized. After redissolving the samples in 0.5 mL of sodium phosphate buffer, we incubated 100-microL aliquots with anti-alpha-hANP for 24 h, then added 125I-labeled alpha-hANP tracer; 24 h later, we separated the bound and free fraction by adding an antibody/polyethylene glycol complex as the second antibody. The sensitivity of the assay was 2 pg per tube (B0-3 SEM). In the useful range of B = 15 to 85% of B0, CVs for within-run and between-run precision did not exceed 8 and 12%, respectively. The 50% intercept of the standard curve was at 12 pg per tube. hANP concentrations for 36 healthy adults ranged from 8 to 68 ng/L.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2936535

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  6 in total

1.  [Atrial natriuretic factor levels and pressure in the pulmonary circulation before and after coronary dilatation].

Authors:  K H Scholz; J Marten; C Herrmann; U Spaar; U Tebbe; K L Neuhaus; H Kreuzer
Journal:  Klin Wochenschr       Date:  1990-08-17

2.  Human atrial natriuretic peptide in patients with type 1 diabetes mellitus: is it related to the development of diabetic nephropathy?

Authors:  E Jungmann; A Felber; S Graeber; U Hillmann; T Haak; K D Palitzsch; K H Usadel
Journal:  Clin Investig       Date:  1993-08

3.  Effects of extreme lateral posture on hemodynamics and plasma atrial natriuretic peptide levels in critically ill patients.

Authors:  T Bein; C Metz; C Keyl; M Pfeifer; K Taeger
Journal:  Intensive Care Med       Date:  1996-07       Impact factor: 17.440

4.  Atrial natriuretic peptide in stable and decompensated chronic obstructive pulmonary disease.

Authors:  K Skwarski; M Lee; L Turnbull; W MacNee
Journal:  Thorax       Date:  1993-07       Impact factor: 9.139

5.  Atrial natriuretic peptide release due to physical exercise in healthy persons and in cardiac patients.

Authors:  D H Petzl; E Hartter; W Osterode; H Böhm; W Woloszczuk
Journal:  Klin Wochenschr       Date:  1987-02-16

6.  Raised circulating plasma levels of atrial natriuretic peptide in adolescent and adult patients with cystic fibrosis and pulmonary artery hypertension.

Authors:  O C Burghuber; E Hartter; M Weissel; W Wolosczcuk; M Götz
Journal:  Lung       Date:  1991       Impact factor: 2.584

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.